RWMEX | UIGIX | RWMEX / UIGIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 23 years | 9 years | - |
Gain YTD | 16.062 | 5.335 | 301% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 195B | 2.08B | 9,398% |
Annual Yield % from dividends | 1.45 | 0.77 | 189% |
Returns for 1 year | 16.82 | 5.92 | 284% |
Returns for 3 years | 15.09 | 2.29 | 660% |
Returns for 5 years | 37.99 | 29.17 | 130% |
Returns for 10 years | 67.00 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GSVTX | 16.45 | N/A | N/A |
Goldman Sachs Large Cap Value Inv | |||
ABRUX | 15.04 | -0.04 | -0.27% |
DSS AmericaFirstMonthlyRisk-OnRisk-Off U | |||
ETIHX | 34.81 | -0.15 | -0.43% |
Eventide Healthcare & Life Sciences I | |||
FDTTX | 25.13 | -0.19 | -0.75% |
Fidelity Advisor Capital Development A | |||
AMIDX | 13.54 | -0.12 | -0.88% |
Amana Developing World Institutional |